Southeast Asia has a huge hepatitis burden—more than HIV and malaria combined

The region needs to enhance awareness and action to eliminate hepatitis, writes WHO regional director for southeast Asia s 

By Poonam Khetrapal Singh
Last Updated: Friday 28 July 2017 | 09:19:17 AM

Each year, viral hepatitis infects millions of people across southeast Asia, causing the death of around 410,000 persons (Credit:  Beth Kanter/Flickr)

Viral Hepatitis is a major public health problem in the South-East Asia Region, and every person has a stake in controlling and eliminating it. Each year, viral hepatitis infects millions of people across the region, causing the death of around 410,000 persons—more than HIV and malaria combined. It is also a major cause of liver cancer and cirrhosis, contributing to premature morbidity and mortality, and undermining economic growth and the push to achieve health and wellbeing for all.

Despite hepatitis’ outsized burden, it is estimated that just one in ten people infected with the disease know their status. Many others remain unaware that effective treatments exist, or that preventive measures are available, from basic hygiene to the hepatitis B vaccine. Regrettably, stigma and discrimination against those suffering the disease remain common.
To overcome these barriers and eliminate hepatitis as a public health threat by 2030, as per regional and global targets, enhanced awareness and understanding of how to prevent, treat and manage the disease is vital.
To achieve this, health authorities across the region can increase the prominence of hepatitis-related information and advocacy. Clear, concise and accurate messaging regarding how hepatitis infection can be prevented, what its signs and symptoms are and how it can be treated is essential to empowering people to take action. Simple hygiene measures such as hand-washing and consumption of safe drinking water and hygienic food, for example, are powerful tools for preventing hepatitis A and E. Messaging targeted towards high-risk groups such as intravenous drug users and sex workers can meanwhile increase uptake of harm-reduction measures, while messaging aimed at political leaders and donors can highlight resource gaps and help obtain high-level buy-in.
Health authorities can likewise expand the hepatitis-related knowledge and skills of health workers at all levels. From nurses and midwives to doctors and technicians, a clear understanding of viral hepatitis testing, treatment and care is needed. This can be done by enhancing medical and other health professional school curricula; creating and disseminating robust guidelines on all aspects of hepatitis testing, treatment and care; and providing specialized training on outbreak management. Clear directives on avoiding unnecessary injections and using ReUse Prevention syringes wherever injections are required can go a long way to decreasing the hepatitis burden. So too can universal uptake of the hepatitis B birth dose vaccine when followed by two-three doses in the first six months of life.
Beyond policy-level interventions, each of us can contribute to raising awareness and helping eliminate the disease in our own way. We can share our experiences of hepatitis infection openly, challenging social taboos. We can express solidarity with persons affected by hepatitis, creating a culture of empathy and care. And we can also take a moment to learn more about the disease, sharing that knowledge with our friends, colleagues and loved ones. As Indian film star and WHO South-East Asia Goodwill Ambassador for Viral Hepatitis Mr Amitabh Bachchan demonstrates, hepatitis infection can happen to anyone at any time, and needn’t be accompanied by shame or guilt. It is a common and treatable disease; it is something we must all acknowledge and face up to. 

WHO South-East Asia is committed to doing this, and to supporting all countries in the Region implement comprehensive strategic action plans to tackle hepatitis. Through our collective resolve we can enhance hepatitis-related awareness and action and eliminate the disease as a public health threat by 2030.

Subscribe to Weekly Newsletter :

Related Story:

World Hepatitis Day: Who can pay for hepatitis C treatment?

Hepatitis afflicts many HIV/AIDS patients, but there is no policy for them

All about hepatitis

IEP Resources:

Global hepatitis report, 2017

Prices, costs, and affordability of new medicines for Hepatitis C in 30 countries: An economic analysis

Status of hepatitis B infection- a decade after hepatitis B vaccination of susceptible Nicobarese, an indigenous tribe of Andaman & Nicobar (A&N) islands with high hepatitis B endemicity

Successes and challenges on the road to cure Hepatitis C

We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.